Current Challenges and Future Perspectives of CAR-T Cell Therapy in Solid Tumors
International Journal of Biology and Life Sciences · 15.11.2026 · 17 (2) · 63-71
DOI: 10.54097/325p1w98 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biology and Life Sciences, online erschienen am 15.11.2026. Verfasst von Qixuan Gu. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Chimeric antigen receptor T-cell (CAR-T) therapy has shown some good results. Clinical Success of Hematological Malignancies and its Efficacy in Solid Tumors. remains constrained. The various biological features of solid tumors are as follows: Heterogeneous antigen expression, poor tumour trafficking and invasion, etc. Immunosuppressive Tumor Microenvironment (TME) and T-cell Exhaustion. It will have little therapeutic effect for CAR-T cells. Although recent studies have shown some good results, these problems are still not fully resolved.This review summarizes the major barriers affecting CAR-T cell therapy in solid tumors and discusses recent advances aimed at overcoming these limitations. First of all, there is tumour antigen heterogeneity and antigen escape; Tumour homing is restricted, intratumoral penetration is poor, there is a suppressive tumour microenvironment, and T-cell function and dysfunction are gradually lost. Recently, some new treatment ideas have been put forward, such as multi-target CAR-T cells, modifications of the TME (tumor microenvironment), and gene-editing technology to construct next-generation CAR-T cells. In short, the above results show that in order to improve the efficacy of CAR-T therapy for solid tumors, many engineering strategies must be integrated to enhance tumour recognition, persistence and antitumor activity. Further progress will be made in cell engineering, gene editing and tumour immunology to advance the development of safer and more effective CAR-T therapy, providing new hope for the treatment of solid tumours.
Zitieren
APA
Gu, Q. (2026). Current Challenges and Future Perspectives of CAR-T Cell Therapy in Solid Tumors. International Journal of Biology and Life Sciences, 17(2), 63-71. https://doi.org/10.54097/325p1w98
Vancouver
Gu Q. Current Challenges and Future Perspectives of CAR-T Cell Therapy in Solid Tumors. International Journal of Biology and Life Sciences. 2026;17(2):63-71. doi:10.54097/325p1w98
BibTeX
@article{Gu2026,
author = {Gu, Qixuan},
title = {Current Challenges and Future Perspectives of CAR-T Cell Therapy in Solid Tumors},
journal = {International Journal of Biology and Life Sciences},
year = {2026},
volume = {17},
number = {2},
pages = {63--71},
doi = {10.54097/325p1w98}
}
EUVIMED